Search For

Current applications of tumor local ablation (TLA) combined with immune checkpoint inhibitors in breast cancer treatment

Current knowledge about immunotherapy resistance for melanoma and potential predictive and prognostic biomarkers

Mechanisms of tyrosine kinase inhibitor resistance in renal cell carcinoma

Emerging roles of 3D-culture systems in tackling tumor drug resistance

Unlocking antitumor immunity with adenosine receptor blockers

Drug resistance in glioblastoma: from chemo- to immunotherapy

Emerging resistance vs. losing response to immune check point inhibitors in renal cell carcinoma: two differing phenomena

Tumor-intrinsic metabolic reprogramming and how it drives resistance to anti-PD-1/PD-L1 treatment

Primary and acquired resistance to first-line therapy for clear cell renal cell carcinoma

Mechanisms and clinical implications in renal carcinoma resistance: narrative review of immune checkpoint inhibitors

Major hurdles of immune-checkpoint inhibitors in pancreatic ductal adenocarcinoma

Remodeling the tumor microenvironment to overcome treatment resistance in HPV-negative head and neck cancer